摘要
目的:检测麻风菌对氨苯砜(DDS)和利福平(RFP)的耐药。方法:收集临床麻风复发病例皮损组织标本,巢式PCR扩增DDS和RFP耐药基因片段,用直接测序鉴定耐药基因突变。结果:在35例复发病例的皮损组织标本中,共检测出12例DDS耐药基因突变,有5种突变型。但未发现利福平耐药菌株。结论:尽管本研究没有发现利福平耐药菌株,但仍应继续开展对利福平耐药的监测。
Objective: To detect drug resistance in relapsed leprosy patients. Methods: Skin lesions were obtained from relapsed leprosy patients. Dapsone (DDS) and rifampicin (RFP) resistant gene segments were tested by nested PCR, and PCR products were sequenced to identify mutations. Results: DDS resistance was discovered in 12 of 35 re- lapsed leprosy cases with five mutation patterns. No RFP- resistant strain was identified. Conclusion: Monitoring RFP resistance should continue, in spite of the negative result in the current study.
出处
《中国麻风皮肤病杂志》
2011年第1期6-8,共3页
China Journal of Leprosy and Skin Diseases
基金
NIH/DMID 05-0097